Cochrane Abstracts
Insulin‐sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Edited (no change to conclusions)
Insulin‐sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Insulin‐sensitising Drugs Versus the Combined Oral Contraceptive Pill for Hirsutism, Acne and Risk of Diabetes, Cardiovascular Disease, and Endometrial Cancer in Polycystic Ovary Syndrome Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review. Accessed 12 August 2020.
Insulin‐sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review. Accessed August 12, 2020.
Insulin‐sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Edited (no change to conclusions). In Cochrane Abstracts Retrieved August 12, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review
Insulin‐sensitising Drugs Versus the Combined Oral Contraceptive Pill for Hirsutism, Acne and Risk of Diabetes, Cardiovascular Disease, and Endometrial Cancer in Polycystic Ovary Syndrome Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2020 August 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin‐sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Edited (no change to conclusions)
ID - 433914
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
